CompletedPhase 2NCT01524848
Pazopanib in Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib
Studying Gastrointestinal stromal tumor
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Scandinavian Sarcoma Group
- Principal Investigator
- Mikael Eriksson, MD PhDScandinavian Sarcoma Group
- Intervention
- Pazopanib(drug)
- Enrollment
- 72 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2012 – 2016
Study locations (16)
- Aarhus University Hospital, dept. of Oncology, Aarhus, Denmark
- Herlev Hospital, dept. of Oncology, Herlev, Denmark
- Helsinki University Hospital, dept. of oncology, Helsingfors, Finland
- Kuopio University Hospital Cancer Center, Kuopio, Finland
- Klinik für Interdisziplinäre Onkologie, Sarkomzentrum Berlin-Brandenburg, Berlin, Germany
- Universitätsklinikum Essen, Innere klinik und Poliklinik, Essen, Germany
- Studienzentrale chirurgische klinik, Universitäts medizin Mannheim, Mannheim, Germany
- Dept of Oncology, Haukeland University Hospital, Bergen, Norway
- Norwegian Radium Hospital, Oslo, Norway
- Dept of Oncology, St Olav Hospital, Trondheim, Norway
- Dept of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden
- Dept of Oncology, Linköping University Hospital, Linköping, Sweden
- Dept of Oncology, Skane University Hospital, Lund, Sweden
- Radiumhemmet, Karolinska University Hospital, Stockholm, Sweden
- Dept of Oncology, Norrland University Hospital, Umeå, Sweden
- +1 more locations on ClinicalTrials.gov
Collaborators
GlaxoSmithKline
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01524848 on ClinicalTrials.govOther trials for Gastrointestinal stromal tumor
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07171203Neoadjuvant Imatinib and Fampridine in KIT Mutant Gastrointestinal Stromal TumorUniversity of California, San Diego
- RECRUITINGNANCT07405125Safety of Robotic Surgery for GISTs at Special Anatomic SitesThe First Affiliated Hospital with Nanjing Medical University
- RECRUITINGPHASE3NCT07218926A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib TherapyGlaxoSmithKline
- RECRUITINGPHASE1NCT06655246A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)Kura Oncology, Inc.
- RECRUITINGNANCT06926374Prospective Evaluation of Cornerstone Robotics Sentire Surgical System in Major Gastrointestinal and Urologic SurgeryChinese University of Hong Kong
- RECRUITINGNANCT07411118RCT of EFTR Versus STER for GIST TreatmentChinese University of Hong Kong
- RECRUITINGPHASE1, PHASE2NCT06630234A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST)Deciphera Pharmaceuticals, LLC
- RECRUITINGPHASE3NCT06640361A Study of Olverembatinib in SDH-deficient GIST.Ascentage Pharma Group Inc.